Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risks for Transition From Therapeutic Hypnotic Use to Abuse
NCT02456532Phase 4Completed
- Sponsor
- Henry Ford Health
- Start
- Aug 2015
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of eszopiclone, zolpidem in Insomnia, sponsored by Henry Ford Health. Started Aug 2015; status: completed.
02
Drugs
eszopiclonezolpidem
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT02456532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02456532.